MedTrace Logo

Dynesys Spinal System Post Market 522 Study

NCT01528072 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 153

Last updated 2020-01-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the safety and fusion rates following posterior lateral fusion with the Dynesys Spinal System used as an adjunct to fusion and compare to literature control.

Conditions

  • Degenerative Spondylolisthesis
  • Pseudoarthrosis

Interventions

DEVICE

Dynesys Spinal System

Dynesys Spinal System will be used for all subjects

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Joel Batts · Zimmer Biomet Spine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01528072 on ClinicalTrials.gov